Lupeol acetate
Lupeol acetate, a bioactive derivative of Lupeol, exhibits oral activity and diverse pharmacological properties including anti-cancer, anti-inflammatory, and anti-diabetic effects. It demonstrates cytotoxicity against Hep-3B and A549 cell lines in vitro and inhibits rheumatoid arthritis in vivo by downregulating key inflammatory mediators such as TNF-α, IL-1β, and COX-2.
Product Specifications
CAS Number
1617-68-1
Product Name Alternative
TNF-α, 3-Acetyllupeol, Lupeol Acetate, Lupeyl acetate, NO Synthase, NOS
Field of Research
Cell Biology, Immunology & Inflammation, Infectious Disease & Virology, Neuroscience
Purity
99.84% (May vary between batches)
Solubility
Ethanol:1 mg/mL (2.13 mM)
Smiles
C[C@]12[C@@] ([C@@]3 ([C@@] (C) (CC1) CC[C@H]3C (C) =C) [H]) (CC[C@]4 ([C@@]2 (C) CC[C@@]5 ([C@]4 (C) CC[C@H] (OC (C) =O) C5 (C) C) [H]) [H]) [H]
Molecular Formula
C32H52O2
Molecular Weight
468.75
Storage Conditions
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
Recombinant Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
Recombinant Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
Recombinant Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
Recombinant Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)